These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1287731)

  • 1. Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease.
    Murphy GM; Ellis WG; Lee YL; Stultz KE; Shrivastava R; Tinklenberg JR; Eng LF
    Prog Brain Res; 1992; 94():475-83. PubMed ID: 1287731
    [No Abstract]   [Full Text] [Related]  

  • 2. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex.
    Beach TG; McGeer EG
    Brain Res; 1988 Nov; 463(2):357-61. PubMed ID: 3196922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.
    Simpson JE; Ince PG; Lace G; Forster G; Shaw PJ; Matthews F; Savva G; Brayne C; Wharton SB;
    Neurobiol Aging; 2010 Apr; 31(4):578-90. PubMed ID: 18586353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.
    Munger EL; Edler MK; Hopkins WD; Ely JJ; Erwin JM; Perl DP; Mufson EJ; Hof PR; Sherwood CC; Raghanti MA
    J Comp Neurol; 2019 May; 527(7):1179-1195. PubMed ID: 30578640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis.
    Cole G; Neal JW; Singhrao SK; Jasani B; Newman GR
    Acta Neuropathol; 1993; 85(5):542-52. PubMed ID: 8493862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease in Down's syndrome. A review.
    Karlinsky H
    J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.
    Murphy GM; Ellis WG
    Biol Psychiatry; 1991 Jul; 30(1):92-106. PubMed ID: 1832566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxigenin-tagged anti-GFAP and multiple labelling of human glia, vessels and beta-amyloid.
    Härtig W; Hausen D; Brauer K; Arendt T; Bigl V; Brückner G
    Neuroreport; 1994 Jan; 5(5):573-6. PubMed ID: 8025246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
    Botez G; Probst A; Ipsen S; Tolnay M
    Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of beta-protein deposits in Alzheimer's cerebral cortices by three-dimensional observation.
    Kimura T; Hisano T; Ueda K; Miyakawa T
    Jpn J Psychiatry Neurol; 1993 Dec; 47(4):909-14. PubMed ID: 8201802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease.
    Cirillo C; Capoccia E; Iuvone T; Cuomo R; Sarnelli G; Steardo L; Esposito G
    Biomed Res Int; 2015; 2015():508342. PubMed ID: 26295040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer's disease.
    Alberdi E; Wyssenbach A; Alberdi M; Sánchez-Gómez MV; Cavaliere F; Rodríguez JJ; Verkhratsky A; Matute C
    Aging Cell; 2013 Apr; 12(2):292-302. PubMed ID: 23409977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcification of the basal ganglia in Down's syndrome and Alzheimer's disease.
    Mann DM
    Acta Neuropathol; 1988; 76(6):595-8. PubMed ID: 2974228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
    Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE
    Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
    Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
    Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic and histochemical development and ageing in patients with Down's syndrome.
    Takashima S; Iida K; Mito T; Arima M
    J Intellect Disabil Res; 1994 Jun; 38 ( Pt 3)():265-73. PubMed ID: 8061472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.